Doctomatic Advances in Latin America and Enters the Health Sector in Ecuador

Doctomatic continues to gain positions in Latin America. The Spanish digital health company has reached an agreement with the Ecuadorian company Medival EC to offer remote or home monitoring services to its clients, according to Frederic Llordachs, co-founder and CEO of Doctomatic.

Thanks to the agreement, Doctomatic enters Ecuador’s healthcare sector with the aim of improving the health and well-being of rural communities in the country. “We strongly believe that the combination of the excellent work done by Medival and the advanced technology of Doctomatic will have a significant impact on the care and follow-up of chronic patients,” said Llordachs.

Medival EC is a company with offices in Guayaquil (Ecuador) founded in 2020 and specialized in telemedicine, especially in the areas of cardiology, endocrinology, geriatrics, rheumatology, physical therapy, and mental health, among others. The company usually establishes alliances with health professionals who have private offices in the communes, precincts, and rural parishes of Ecuador.

Read more about Doctomatic and find the latest business news of the day with the Born2Invest mobile app.

Doctomatic is also active in Brazil and Mexico

Doctomatic’s entry into Ecuador comes after the Barcelona start-up has reached an agreement with the Brazilian Unimed Cascavel to offer remote or home monitoring services to its clients.

Based on the agreement, Doctomatic hopes to monitor between 100 patients and 200 patients in the first sixty days, until a minimum of between 4,000 patients and 5,000 patients can be reached. Unimed Cascavel is part of the Sistema Unimed health cooperative and is headquartered in the Brazilian city of Cascavel, located in the western region of the state of Paraná. The group offers its services to more than fifteen million people throughout Brazil and works with more than 73,000 companies.

In Brazil, Doctomatic also has agreements with Domum and Clude Saude. The first company is a healthcare group with activity in Sao Paulo, Rio de Janeiro, and Paraná and has the brands Carebiz, DigiCare, Provide, Semper, Telecare, and Vamos Cuidar. Clude Saude, for its part, is a Brazilian virtual insurer, born in 2019 in Sao Paulo, which offers virtual healthcare services based on monthly subscriptions.

The company will seek to increase capital by half a million euros after the summer

Likewise, Doctomatic has a shared office space in the district of Polanco, Mexico. The objective of the Spanish company is to continue growing in that country and it is working on agreements with insurers and hospital groups. For now, Grupo Mexicano de Hospitales (GMH) has chosen the Spanish company to improve the quality of life of chronic patients.

Doctomatic was founded in 2021 with the aim of offering, through a digital platform, the remote management and control of chronic patients. To date, the company has raised more than 400,000 euros with the support of Carlos Blanco and Oriol Juncosa, both from the Encomenda Smart Capital fund, and Ship2B Ventures, a venture capital firm that invests in start-ups with a high social and environmental impact.

Doctomatic uses artificial intelligence capable of reading data from images to find out if a person may or may not have a disease. The company’s clients include hospitals, doctors, and insurance companies. Doctomatic’s forecast is to reach break-even in 2023 and in a matter of five years reach five million patients and bill more than twenty million euros. In addition, after the summer the company will seek half a million euros through a new round of financing.

__

(Featured image by DEZALB via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.